▶ 調査レポート

非コルチコステロイド抗炎症点眼薬の世界市場レポート2020

• 英文タイトル:Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。非コルチコステロイド抗炎症点眼薬の世界市場レポート2020 / Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Report 2020 / 20QY06-08201資料のイメージです。• レポートコード:20QY06-08201
• 出版社/出版日:QYResearch / 2020年6月1日
• レポート形態:英文、PDF、146ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥428,000 (USD4,000)▷ お問い合わせ
  Multi User¥642,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥856,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、非コルチコステロイド抗炎症点眼薬のグローバル市場について種類別(オクフェン、ムガベ、ジクロフェナク、その他)、用途別(大人、子供)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・非コルチコステロイド抗炎症点眼薬市場の概要
・世界の主要地域別非コルチコステロイド抗炎症点眼薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の非コルチコステロイド抗炎症点眼薬市場規模2015-2026:種類別(オクフェン、ムガベ、ジクロフェナク、その他)
・世界の非コルチコステロイド抗炎症点眼薬市場規模2015-2026:用途別(大人、子供)
・非コルチコステロイド抗炎症点眼薬の北米市場規模2015-2020
・非コルチコステロイド抗炎症点眼薬のヨーロッパ市場規模2015-2020
・非コルチコステロイド抗炎症点眼薬の中国市場規模2015-2020
・非コルチコステロイド抗炎症点眼薬の日本市場規模2015-2020
・非コルチコステロイド抗炎症点眼薬の東南アジア市場規模2015-2020
・非コルチコステロイド抗炎症点眼薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Novartis AG、Allergan, Inc.、Meda Pharmaceuticals Inc、Bausch & Lomb Inc、Cigna、Similasan Corporation、Visine、Alcon、Viva Opti-Free、Bausch & Lomb、Systane、Rite Aid、Walgreens、Staples、Clear eyes)
・非コルチコステロイド抗炎症点眼薬の製造コスト分析
・販売チャネル、流通業者、顧客
・非コルチコステロイド抗炎症点眼薬の市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Non Corticosteroid Anti-inflammatory Eyedrops Market
The global Non Corticosteroid Anti-inflammatory Eyedrops market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Non Corticosteroid Anti-inflammatory Eyedrops Scope and Market Size
The global Non Corticosteroid Anti-inflammatory Eyedrops market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non Corticosteroid Anti-inflammatory Eyedrops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Non Corticosteroid Anti-inflammatory Eyedrops market is segmented into
Ocufen
Mugabe
Diclofenac
Others

Segment by Application, the Non Corticosteroid Anti-inflammatory Eyedrops market is segmented into
Adult
Children
The Non Corticosteroid Anti-inflammatory Eyedrops market is analysed and market size information is provided by regions (countries). Segment by Application, the Non Corticosteroid Anti-inflammatory Eyedrops market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Non Corticosteroid Anti-inflammatory Eyedrops Market Share Analysis
Non Corticosteroid Anti-inflammatory Eyedrops market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Non Corticosteroid Anti-inflammatory Eyedrops business, the date to enter into the Non Corticosteroid Anti-inflammatory Eyedrops market, Non Corticosteroid Anti-inflammatory Eyedrops product introduction, recent developments, etc.
The major vendors covered:
Novartis AG
Allergan, Inc.
Meda Pharmaceuticals Inc
Bausch & Lomb Inc
Cigna
Similasan Corporation
Visine
Alcon
Viva Opti-Free
Bausch & Lomb
Systane
Rite Aid
Walgreens
Staples
Clear eyes

レポート目次

Table of Contents

1 Non Corticosteroid Anti-inflammatory Eyedrops Market Overview
1.1 Non Corticosteroid Anti-inflammatory Eyedrops Product Scope
1.2 Non Corticosteroid Anti-inflammatory Eyedrops Segment by Type
1.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2020-2026)
1.2.2 Ocufen
1.2.3 Mugabe
1.2.4 Diclofenac
1.2.5 Others
1.3 Non Corticosteroid Anti-inflammatory Eyedrops Segment by Application
1.3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Comparison by Application (2020-2026)
1.3.2 Adult
1.3.3 Children
1.4 Non Corticosteroid Anti-inflammatory Eyedrops Market Estimates and Forecasts (2015-2026)
1.4.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Growth Rate (2015-2026)
1.4.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue and Growth Rate (2015-2026)
1.4.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Price Trends (2015-2026)

2 Non Corticosteroid Anti-inflammatory Eyedrops Estimate and Forecast by Region
2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2015-2020)
2.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region (2015-2020)
2.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Non Corticosteroid Anti-inflammatory Eyedrops Estimates and Projections (2015-2026)
2.4.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Estimates and Projections (2015-2026)
2.4.3 China Non Corticosteroid Anti-inflammatory Eyedrops Estimates and Projections (2015-2026)
2.4.4 Japan Non Corticosteroid Anti-inflammatory Eyedrops Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Estimates and Projections (2015-2026)
2.4.6 India Non Corticosteroid Anti-inflammatory Eyedrops Estimates and Projections (2015-2026)
3 Global Non Corticosteroid Anti-inflammatory Eyedrops Competition Landscape by Players
3.1 Global Top Non Corticosteroid Anti-inflammatory Eyedrops Players by Sales (2015-2020)
3.2 Global Top Non Corticosteroid Anti-inflammatory Eyedrops Players by Revenue (2015-2020)
3.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Corticosteroid Anti-inflammatory Eyedrops as of 2019)
3.4 Global Non Corticosteroid Anti-inflammatory Eyedrops Average Price by Company (2015-2020)
3.5 Manufacturers Non Corticosteroid Anti-inflammatory Eyedrops Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Non Corticosteroid Anti-inflammatory Eyedrops Players (Opinion Leaders)
4 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Type
4.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Historic Market Review by Type (2015-2020)
4.1.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
4.1.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2015-2020)
4.1.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Type (2014-2020)
4.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Type (2021-2026)
4.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Forecast by Type (2021-2026)
4.2.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Price Forecast by Type (2021-2026)
5 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Application
5.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Historic Market Review by Application (2015-2020)
5.1.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2015-2020)
5.1.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2015-2020)
5.1.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Application (2015-2020)
5.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Application (2021-2026)
5.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Forecast by Application (2021-2026)
5.2.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Price Forecast by Application (2021-2026)

3 North America Non Corticosteroid Anti-inflammatory Eyedrops Market Facts & Figures
3.2 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company (2015-2020)
3.3 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
3.4 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2015-2020)

4 Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Facts & Figures
4.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company (2015-2020)
4.3 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
4.4 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2015-2020)

5 China Non Corticosteroid Anti-inflammatory Eyedrops Market Facts & Figures
5.2 China Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company (2015-2020)
5.3 China Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
5.4 China Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2015-2020)

6 Japan Non Corticosteroid Anti-inflammatory Eyedrops Market Facts & Figures
6.2 Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company (2015-2020)
6.3 Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
6.4 Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2015-2020)

7 Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Market Facts & Figures
7.2 Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2015-2020)

8 India Non Corticosteroid Anti-inflammatory Eyedrops Market Facts & Figures
8.2 India Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company (2015-2020)
8.3 India Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
8.4 India Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Non Corticosteroid Anti-inflammatory Eyedrops Business
12.1 Novartis AG
12.1.1 Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.1.2 Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.1.3 Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.1.5 Novartis AG Recent Development
12.2 Allergan, Inc.
12.2.1 Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.2.2 Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.2.3 Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.2.5 Allergan, Inc. Recent Development
12.3 Meda Pharmaceuticals Inc
12.3.1 Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.3.2 Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.3.3 Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.3.5 Meda Pharmaceuticals Inc Recent Development
12.4 Bausch & Lomb Inc
12.4.1 Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.4.2 Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.4.3 Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.4.5 Bausch & Lomb Inc Recent Development
12.5 Cigna
12.5.1 Cigna Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.5.2 Cigna Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.5.3 Cigna Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Cigna Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.5.5 Cigna Recent Development
12.6 Similasan Corporation
12.6.1 Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.6.2 Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.6.3 Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.6.5 Similasan Corporation Recent Development
12.7 Visine
12.7.1 Visine Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.7.2 Visine Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.7.3 Visine Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Visine Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.7.5 Visine Recent Development
12.8 Alcon
12.8.1 Alcon Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.8.2 Alcon Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.8.3 Alcon Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Alcon Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.8.5 Alcon Recent Development
12.9 Viva Opti-Free
12.9.1 Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.9.2 Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.9.3 Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.9.5 Viva Opti-Free Recent Development
12.10 Bausch & Lomb
12.10.1 Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.10.2 Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.10.3 Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.10.5 Bausch & Lomb Recent Development
12.11 Systane
12.11.1 Systane Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.11.2 Systane Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.11.3 Systane Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Systane Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.11.5 Systane Recent Development
12.12 Rite Aid
12.12.1 Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.12.2 Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.12.3 Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.12.5 Rite Aid Recent Development
12.13 Walgreens
12.13.1 Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.13.2 Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.13.3 Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.13.5 Walgreens Recent Development
12.14 Staples
12.14.1 Staples Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.14.2 Staples Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.14.3 Staples Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Staples Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.14.5 Staples Recent Development
12.15 Clear eyes
12.15.1 Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Corporation Information
12.15.2 Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Business Overview and Total Revenue
12.15.3 Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Products Offered
12.15.5 Clear eyes Recent Development

13 Non Corticosteroid Anti-inflammatory Eyedrops Manufacturing Cost Analysis
13.1 Non Corticosteroid Anti-inflammatory Eyedrops Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Non Corticosteroid Anti-inflammatory Eyedrops
13.4 Non Corticosteroid Anti-inflammatory Eyedrops Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Non Corticosteroid Anti-inflammatory Eyedrops Distributors List
14.3 Non Corticosteroid Anti-inflammatory Eyedrops Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) Comparison by Application (2020-2026)
Table 3. Global Market Non Corticosteroid Anti-inflammatory Eyedrops Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Region (2015-2020)
Table 5. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2015-2020)
Table 6. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Region (2015-2020)
Table 8. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share Forecast by Region (2021-2026)
Table 12. Global Non Corticosteroid Anti-inflammatory Eyedrops (K Units) of Key Companies (2015-2020)
Table 13. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Company (2015-2020)
Table 14. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Company (2015-2020)
Table 16. Global Non Corticosteroid Anti-inflammatory Eyedrops by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Corticosteroid Anti-inflammatory Eyedrops as of 2019)
Table 17. Global Non Corticosteroid Anti-inflammatory Eyedrops Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Non Corticosteroid Anti-inflammatory Eyedrops Manufacturing Sites and Area Served
Table 19. Manufacturers Non Corticosteroid Anti-inflammatory Eyedrops Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Non Corticosteroid Anti-inflammatory Eyedrops Players
Table 22. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Type (2015-2020)
Table 23. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Type (2015-2020)
Table 24. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (K Units) by Type (2015-2020)
Table 26. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Type (2021-2026)
Table 27. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Type (2021-2026)
Table 29. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (K Units) by Type (2021-2026)
Table 30. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Application (2015-2020)
Table 31. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Application (2015-2020)
Table 32. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (K Units) by Application (2015-2020)
Table 34. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Application (2021-2026)
Table 35. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Application (2021-2026)
Table 36. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Application (2021-2026)
Table 38. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (K Units) by Application (2021-2026)
Table 39. United States Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Company (2015-2020)
Table 40. United States Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company (2015-2020)
Table 41. United States Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Type (2015-2020)
Table 42. United States Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
Table 43. United States Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Application (2015-2020)
Table 44. United States Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2015-2020)
Table 45. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Company (2015-2020)
Table 46. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company (2015-2020)
Table 47. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Type (2015-2020)
Table 48. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
Table 49. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Application (2015-2020)
Table 50. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
Table 51. China Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Company (2015-2020)
Table 52. China Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company (2015-2020)
Table 53. China Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Type (2015-2020)
Table 54. China Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
Table 55. China Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Application (2015-2020)
Table 56. China Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2015-2020)
Table 57. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Company (2015-2020)
Table 58. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company (2015-2020)
Table 59. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Type (2015-2020)
Table 60. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
Table 61. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Application (2015-2020)
Table 62. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2015-2020)
Table 69. India Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Company (2015-2020)
Table 70. India Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company (2015-2020)
Table 71. India Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Type (2015-2020)
Table 72. India Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2015-2020)
Table 73. India Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Application (2015-2020)
Table 74. India Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2015-2020)
Table 75. Novartis AG Corporation Information
Table 76. Novartis AG Description and Business Overview
Table 77. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 79. Novartis AG Recent Development
Table 80. Allergan, Inc. Corporation Information
Table 81. Allergan, Inc. Description and Business Overview
Table 82. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 84. Allergan, Inc. Recent Development
Table 85. Meda Pharmaceuticals Inc Corporation Information
Table 86. Meda Pharmaceuticals Inc Description and Business Overview
Table 87. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 89. Meda Pharmaceuticals Inc Recent Development
Table 90. Bausch & Lomb Inc Corporation Information
Table 91. Bausch & Lomb Inc Description and Business Overview
Table 92. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 94. Bausch & Lomb Inc Recent Development
Table 95. Cigna Corporation Information
Table 96. Cigna Description and Business Overview
Table 97. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 99. Cigna Recent Development
Table 100. Similasan Corporation Corporation Information
Table 101. Similasan Corporation Description and Business Overview
Table 102. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 104. Similasan Corporation Recent Development
Table 105. Visine Corporation Information
Table 106. Visine Description and Business Overview
Table 107. Visine Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Visine Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 109. Visine Recent Development
Table 110. Alcon Corporation Information
Table 111. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Alcon Description and Business Overview
Table 113. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 114. Alcon Recent Development
Table 115. Viva Opti-Free Corporation Information
Table 116. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Viva Opti-Free Description and Business Overview
Table 118. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 119. Viva Opti-Free Recent Development
Table 120. Bausch & Lomb Corporation Information
Table 121. Bausch & Lomb Description and Business Overview
Table 122. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 124. Bausch & Lomb Recent Development
Table 125. Systane Corporation Information
Table 126. Systane Description and Business Overview
Table 127. Systane Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Systane Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 129. Systane Recent Development
Table 130. Rite Aid Corporation Information
Table 131. Rite Aid Description and Business Overview
Table 132. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 134. Rite Aid Recent Development
Table 135. Walgreens Corporation Information
Table 136. Walgreens Description and Business Overview
Table 137. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 139. Walgreens Recent Development
Table 140. Staples Corporation Information
Table 141. Staples Description and Business Overview
Table 142. Staples Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Staples Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 144. Staples Recent Development
Table 145. Clear eyes Corporation Information
Table 146. Clear eyes Description and Business Overview
Table 147. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 149. Clear eyes Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Non Corticosteroid Anti-inflammatory Eyedrops Distributors List
Table 153. Non Corticosteroid Anti-inflammatory Eyedrops Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Non Corticosteroid Anti-inflammatory Eyedrops Product Picture
Figure 2. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Application in 2020 & 2026
Figure 6. Adult Examples
Figure 7. Children Examples
Figure 8. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Non Corticosteroid Anti-inflammatory Eyedrops Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Non Corticosteroid Anti-inflammatory Eyedrops Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Non Corticosteroid Anti-inflammatory Eyedrops Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Non Corticosteroid Anti-inflammatory Eyedrops Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Non Corticosteroid Anti-inflammatory Eyedrops Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Non Corticosteroid Anti-inflammatory Eyedrops Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Non Corticosteroid Anti-inflammatory Eyedrops Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Non Corticosteroid Anti-inflammatory Eyedrops Players Market Share by Revenue in Non Corticosteroid Anti-inflammatory Eyedrops 2015 & 2019
Figure 26. Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Type (2015-2020)
Figure 28. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Application (2015-2020)
Figure 30. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type in 2019
Figure 32. United States Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type in 2019
Figure 33. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company in 2019
Figure 34. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type in 2019
Figure 35. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application in 2019
Figure 36. China Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company in 2019
Figure 37. China Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type in 2019
Figure 38. China Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application in 2019
Figure 39. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company in 2019
Figure 40. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type in 2019
Figure 41. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application in 2019
Figure 42. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company in 2019
Figure 43. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type in 2019
Figure 44. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application in 2019
Figure 45. India Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Company in 2019
Figure 46. India Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type in 2019
Figure 47. India Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application in 2019
Figure 48. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Allergan, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Meda Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bausch & Lomb Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Cigna Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Similasan Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Visine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Alcon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Viva Opti-Free Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Bausch & Lomb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Systane Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Rite Aid Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Walgreens Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Staples Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Clear eyes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Key Raw Materials Price Trend
Figure 64. Manufacturing Cost Structure of Non Corticosteroid Anti-inflammatory Eyedrops
Figure 65. Manufacturing Process Analysis of Non Corticosteroid Anti-inflammatory Eyedrops
Figure 66. Non Corticosteroid Anti-inflammatory Eyedrops Industrial Chain Analysis
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. Porter's Five Forces Analysis
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed